CAD 0.41
(5.19%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 21.51 Million CAD | 35.09% |
2022 | 16.22 Million USD | 0.99% |
2021 | 16.06 Million CAD | 59.65% |
2020 | 10.06 Million CAD | 17.48% |
2019 | 8.56 Million CAD | 7334.73% |
2018 | 115.19 Thousand CAD | -6.68% |
2017 | 123.44 Thousand CAD | -10.01% |
2016 | 137.16 Thousand CAD | -25.62% |
2015 | 184.41 Thousand CAD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 4.69 Million USD | -4.62% |
2024 Q2 | 5.47 Million USD | 16.66% |
2023 Q2 | 3.3 Million USD | -12.71% |
2023 Q1 | 3.79 Million USD | -4.67% |
2023 FY | 21.91 Million CAD | 35.09% |
2023 Q4 | 4.91 Million USD | 10.65% |
2023 Q3 | 4.44 Million USD | 34.32% |
2022 Q3 | 5.81 Million CAD | -4.79% |
2022 Q1 | 4.82 Million CAD | -12.36% |
2022 Q2 | 6.1 Million CAD | 26.62% |
2022 FY | 16.22 Million USD | 0.99% |
2022 Q4 | 3.97 Million USD | -31.6% |
2021 Q1 | 3.79 Million CAD | -9.86% |
2021 Q2 | 3.03 Million CAD | -20.14% |
2021 Q3 | 3.72 Million CAD | 22.76% |
2021 Q4 | 5.5 Million CAD | 47.74% |
2021 FY | 16.06 Million CAD | 59.65% |
2020 Q1 | 1.71 Million CAD | -33.32% |
2020 Q3 | 2.18 Million CAD | 12.01% |
2020 Q4 | 4.21 Million CAD | 92.94% |
2020 Q2 | 1.95 Million CAD | 14.02% |
2020 FY | 10.06 Million CAD | 17.48% |
2019 Q1 | 1.56 Million CAD | 0.0% |
2019 FY | 8.56 Million CAD | 7334.73% |
2019 Q4 | 2.56 Million CAD | 12.43% |
2019 Q3 | 2.28 Million CAD | 5.96% |
2019 Q2 | 2.15 Million CAD | 37.79% |
2018 FY | 115.19 Thousand CAD | -6.68% |
2017 FY | 123.44 Thousand CAD | -10.01% |
2016 FY | 137.16 Thousand CAD | -25.62% |
2015 FY | 184.41 Thousand CAD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Therma Bright Inc. | 3.62 Million CAD | -493.116% |
Theralase Technologies Inc. | 562.13 Thousand CAD | -3726.938% |
VentriPoint Diagnostics Ltd. | 4.97 Million CAD | -332.592% |